BSG and astrocytoma (excluding glioblastoma): High-grade brain tumors overexpress EMMPRIN and EMMPRIN expression positively correlates with WHO grades in human astrocytomas and meningiomas, suggesting that EMMPRIN may be a therapeutic target of brain tumor.